TY - JOUR
T1 - A proposal on the first Japanese practical guidance for the return of individual genomic results in research settings
AU - Aizawa, Yayoi
AU - Nagami, Fuji
AU - Ohashi, Noriko
AU - Kato, Kazuto
N1 - Funding Information:
The third pertinent issue is the expense associated with ROGRR. When implementing ROGRR, it is necessary to secure the expense budget required to conduct confirmation testing, recontact research participants, and return their results, especially in the case of secondary use of stored samples and information. However, in our interviews of researchers, some of them stated that it is difficult to figure out whether it is possible to include expenses related to ROGRR into their budget, particularly in the research where ROGRR is not included in the original protocol. Much research that accompanies large-scale genome analysis in Japan is conducted using grants predominantly funded by government agencies. We consider the guidance provided by said funding agencies regarding ROGRR and distinct policy on its implementation in the budget would help
Publisher Copyright:
© 2019, The Author(s), under exclusive licence to The Japan Society of Human Genetics.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Large-scale, low-cost genome analysis has become possible with next-generation sequencing technology, which is currently used in research and clinical practice. Many attempts of returning individual genomic results have commenced not only in clinical practice, but also in research settings of several countries. In Japan, the government guidelines include a section on the disclosure of genetic information regarding genome analysis in research. However, no practical guidance for the return of individual genomic results in research settings (ROGRR) currently exists. We propose practical guidance regarding ROGRR in Japan based on extensive research, including a literature review of related previous studies, an examination of the relevant legislation in Japan, and interviews with stakeholders. The guidance we developed consists of “Points to consider” and “Issues for further discussion and consideration.” The “Points to consider” were divided into five parts, from preliminary review before discussion of policy, to the actual return and follow-up process, in the order of the assumed ROGRR process. It is anticipated that a situation will arise where numerous research projects will consider ROGRR carefully and realistically in the future, and in the process of drafting such practical guidance, various issues requiring continuous discussion will emerge. The necessities of continuous discussion concerning ROGRR in Japan’s context is increasing, particularly in terms of the ethical, legal, and social implications. We believe such discussions and considerations may contribute to creating a new system that will increase availability of personalized medicine and prevention using genetic information, allowing them to become useful to the broader population.
AB - Large-scale, low-cost genome analysis has become possible with next-generation sequencing technology, which is currently used in research and clinical practice. Many attempts of returning individual genomic results have commenced not only in clinical practice, but also in research settings of several countries. In Japan, the government guidelines include a section on the disclosure of genetic information regarding genome analysis in research. However, no practical guidance for the return of individual genomic results in research settings (ROGRR) currently exists. We propose practical guidance regarding ROGRR in Japan based on extensive research, including a literature review of related previous studies, an examination of the relevant legislation in Japan, and interviews with stakeholders. The guidance we developed consists of “Points to consider” and “Issues for further discussion and consideration.” The “Points to consider” were divided into five parts, from preliminary review before discussion of policy, to the actual return and follow-up process, in the order of the assumed ROGRR process. It is anticipated that a situation will arise where numerous research projects will consider ROGRR carefully and realistically in the future, and in the process of drafting such practical guidance, various issues requiring continuous discussion will emerge. The necessities of continuous discussion concerning ROGRR in Japan’s context is increasing, particularly in terms of the ethical, legal, and social implications. We believe such discussions and considerations may contribute to creating a new system that will increase availability of personalized medicine and prevention using genetic information, allowing them to become useful to the broader population.
UR - http://www.scopus.com/inward/record.url?scp=85077156048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077156048&partnerID=8YFLogxK
U2 - 10.1038/s10038-019-0697-y
DO - 10.1038/s10038-019-0697-y
M3 - Article
C2 - 31873219
AN - SCOPUS:85077156048
SN - 1434-5161
VL - 65
SP - 251
EP - 261
JO - Journal of Human Genetics
JF - Journal of Human Genetics
IS - 3
ER -